SCHEMBL6951207

SCHEMBL6951207

CC(C)c1c(O)cccc1C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.55
ALDH1A1 P00352 5/20 0.55
HPGD P15428 4/20 0.55
MAPT P10636 2/20 0.55
HSD17B10 Q99714 2/20 0.55
TSHR P16473 1/20 0.55
IRAK4 Q9NWZ3 1/20 0.44
G6PD P11413 1/20 0.41
CASP7 P55210 1/20 0.41
CASP6 P55212 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA9 Q16790 3/20 0.40
CA12 O43570 2/20 0.40
CA7 P43166 2/20 0.40
CA14 Q9ULX7 2/20 0.40
PARP1 P09874 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2977145 0.88 IRAK4 (0.50) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL5230216 0.82 ALDH1A1 (0.54) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL13773187 0.82 THRB (0.48) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL30797325 0.81 IRAK4 (0.44) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL458410 0.81 IRAK4 (0.44) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL3628076 0.81 IRAK4 (0.44) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL16592837 0.81 IRAK4 (0.44) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL1832020 0.81 IRAK4 (0.44) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL8882007 0.79 KDM4E (0.57) KDM4EALDH1A1HPGDMAPTHSD17B10
Hydrochloric Acid SCHEMBL29160773 0.79 IRAK4 (0.43) KDM4EALDH1A1HPGDMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996446-B1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2003-09-17 EP disclosed
US-6562832-B1 Cytokine suppressive anti-inflammatory drugs, capable of inhibiting the CSBP/p38/RK kinase SMITHKLINE BEECHAM CORPORATION 2003-05-13 US disclosed
EP-0996446-A4 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2001-08-29 EP disclosed
EP-0996446-A1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-03 EP disclosed
US-6046208-A TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ENDOTOXEMIA AND/OR TOXIC SHOCK SYNDROME, OTHER ACUTE OR CHRONIC INFLAMMATORY DISEASE STATES SUCH AS THE INFLAMMATORY REACTION INDUCED BY ENDOTOXIN OR INFLAMMATORY BOWEL DISEASE SMITHKLINE BEECHAM CORPORATION (US) 2000-04-04 US disclosed
WO-1999001131-A1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO disclosed